Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
19 07 2020
19 07 2020
Historique:
entrez:
21
7
2020
pubmed:
21
7
2020
medline:
21
7
2020
Statut:
epublish
Résumé
An amendment to this paper has been published and can be accessed via the original article.
Identifiants
pubmed: 32684162
doi: 10.1186/s13063-020-04608-4
pii: 10.1186/s13063-020-04608-4
pmc: PMC7370449
doi:
Types de publication
Journal Article
Published Erratum
Langues
eng
Sous-ensembles de citation
IM
Pagination
660Commentaires et corrections
Type : ErratumFor
Références
Trials. 2019 Apr 3;20(1):191
pubmed: 30944040